Navigation Links
Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association

ombination with other cancer therapies and in a number of cancer types are underway or planned.

About Pharmion

Pharmion is a biopharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic cancer drug, Vidaza(R), a DNA demethylating agent. For additional information about Pharmion, please visit Pharmion's website at http://www.pharmion.com.

About GPC Biotech

GPC Biotech AG is a publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs. GPC Biotech's lead product candidate satraplatin is currently under review by the U.S. FDA for hormone-refractory prostate cancer patients whose prior chemotherapy has failed. GPC Biotech is also developing a monoclonal antibody with a novel mechanism-of-action against a variety of lymphoid tumors, currently in Phase 1 clinical development, and has ongoing drug development and discovery programs that leverage its expertise in kinase inhibitors. GPC Biotech AG is headquartered in Martinsried/Munich (Germany), and has a wholly owned U.S. subsidiary headquartered in Princeton, New Jersey. For additional information, please visit GPC Biotech's Web site at http://www.gpc-biotech.com.

This press release contains forward-looking statements, which express the current beliefs and expectations of the management of GPC Biotech AG and Pharmion Corporation, including statements about the status of the FDA review process. Such statements are based on current expectations and are subject to risks and uncertainties, many of which are beyond our control, that could cause future results, performance or achie
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
6. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy

Post Your Comments:
(Date:11/6/2009)...Newswire-FirstCall/ -- Caraco Pharmaceutical Labor...rolac tromethamine ophthalmic solution, 0.5% follo...ministration (FDA) for Sun Pharma,s Abbreviated Ne... ophthalmic solution on the first day following pa...rapeutically equivalent to Acular® Ophthalmic...
(Date:11/6/2009)... America,s Specialty Med... of mid-market and smaller innovator pharmaceutica...962, the "Affordable Health Care for America Act,"...se smaller companies fear that the cumulative effe...r their efforts to bring new medicines to market. ...
(Date:11/6/2009)...ov. 6 Facet Solutions, Inc. announ...f Archus Orthopedics. The acquisition creates an u..., intellectual property and clinical experience in... patients suffering from lumbar spinal stenosis," ... Pardo. "This consolidation further strengthens F...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Facet Solutions Acquires Archus Orthopedics 2The Chinese Drywall Complaint Center Says There is No Independence Day for Homeowners in Florida Texas or Other States With Toxic Chinese Drywall 50236 1The Chinese Drywall Complaint Center Says There is No Independence Day for Homeowners in Florida Texas or Other States With Toxic Chinese Drywall 50236 2The Chinese Drywall Complaint Center Says There is No Independence Day for Homeowners in Florida Texas or Other States With Toxic Chinese Drywall 50236 3Paraplegic Takes Leap of Faith for Treatment in India 50232 1Paraplegic Takes Leap of Faith for Treatment in India 50232 2Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 1Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 2Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 3Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 4Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 5Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 6Data Demonstrates Long Term Reduction In Seizure Frequency With Novel Once Daily Anti Epileptic Zebinix 28R 29 4660 7
(Date:11/8/2009)...lth advocates committed to achieving meaningful he... "Tonight the U.S. Hous...ice of America,s families by passing the Affordabl... deliver, without delay, on the promise of meaning... President and CEO of the National Alliance for Hi...
(Date:11/8/2009)...Secure the Stability of Medicare ,, HOUSTON, N...table to: J. James Rohack, M.D., President, Americ...newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,...eform bill, which will help improve the health sys...t passage of H.R. 3961 to secure the stability of ...
(Date:11/8/2009)...rking Families vs. Insurance Companies ,, HARR...the heels of an historic late night vote in the Ho... care reform bill, the Pennsylvania AFL-CIO releas...ives voted on HR 3962, the Affordable Health Care ...sed Saturday evening by a vote of 220 to 215, take...
(Date:11/7/2009).../ -- Karen Ignagni, President and CEO of America,s...wing statement today on House passage of H.R. 3962...ve health care reform, and we have contributed to ...f how health insurance is provided. Earlier this y...of pre-existing condition exclusions, no longer ba...
(Date:11/7/2009)...- The American Medical Association (AMA) proudly p...ily Violence Prevention Fund, with the Citation fo...olicy-making meeting. The Citation for Distinguis...Delegates bestows on a non-physician. ,, (Log.../AMALOGO ) ,, "Ms. James has worked selflessl...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Family Violence Prevention Expert 2
... likely to reduce the risk of contacting HIV from .... A recent study involved 3,000 HIV negative men i...cised and other half were not circumcised. They ...umcised men contracted the virus. Further researc...
...olled for early health check up programs and atten...be healthier adults than those who do not. A ...ildren who had participated early in these health ... Early Education Program that had community based ...
... by the ‘Delhi High Court’ on Tuesday Justice Vikr... Hospital to compensate Manju a 12 year old for th...the hospital. He wanted to be informed in the next...eplacement and fixation of fracture dislocation of...
...e to Listeria can be life-threatening unless vigi...ing to the report published by Food Safety Author...tion can be as much as 30% associated with Listeri...ociated with L. monocytogenes is uncertain, howeve...
...g from problem gambling behavior may share their p...drug addicts and alcoholics. Researchers have...em gambling behavior in people and have found mark...vior may not represent the entire gamut of people ...
... Bath in England an interesting study has been con.../ men. This is despite the popular notion that th...one as yet knows. “Until fairly recently it ... the case,” said Dr Ed Keogh a psychologist from t...
Other Medicine News:Health News:Listeria Food Poisoning Can Be Dangerous In Pregnant Women And Elderly 2Health News:Gender difference in Pain Experience - Women feel More Pain than men 2
...to provide fast and accurate measurements of patie...identification and quantitation of hemoglobin vari...control., ,The A1c assay combines the speed an...affinity columns. The result is a precise assessme...
Roche COMPACT 3 Blood Gas Analyzer
IRMA TRUPOINT Blood Analysis System
Flatbed Agitator PFS42
Medicine Products: